MediPharm Labs sells Australian facility for $6.2M

Mugglehead
By Natalia Buendia CalvilloJul 12, 2022, 10:39 pm235 pts
MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) has sold its Australian facility and will move all manufacturing to the Canadian facility. On Wednesday, the pharmaceutical company specialized in cannabinoids said it entered into a $6.2 million ($6.9 AUD) share purchase agreement with OneLife…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Week in Weed – July 5, 2025 68

California Cannabis Operators Warn That New Tax Hike ‘Could Kill This Industry’ 61

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.